Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baiyuan Yang

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Bioorganic & Medicinal Chemistry Letters|December 24, 2023
Synthesis and structure-activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agentsBaiyuan Yang, Paridhi Sukheja, Bo Qin, et al.
NPJ Parkinson'S Disease|October 11, 2024
Machine learning model base on metabolomics and proteomics to predict cognitive impairment in Parkinson's diseaseBaiyuan Yang, Yongyun Zhu, Kelu Li, et al.
Angewandte Chemie (International Ed. in English)|February 2, 2018
Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial ActivityMichael B Harbut, Baiyuan Yang, Renhe Liu, et al.
The Journal of Biological Chemistry|December 10, 2025
Inhibition of de novo fatty acid synthesis in Mycobacterium tuberculosisEmma K Roszkowski, Sarita Charap, Christine R Montague, et al.
Angewandte Chemie (International Ed. in English)|August 18, 2017
Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular ThiophenesRenhe Liu, Xiaoxuan Lyu, Sarah M Batt, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2018
Repurposing isoxazoline veterinary drugs for control of vector-borne human diseasesMarie Miglianico, Maarten Eldering, Hannah Slater, et al.
Nature|July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.
Science Translational Medicine|May 10, 2019
Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infectionsMalina A Bakowski, Roohollah Kazem Shiroodi, Renhe Liu, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Bioorganic & Medicinal Chemistry Letters|December 24, 2023
Synthesis and structure-activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agentsBaiyuan Yang, Paridhi Sukheja, Bo Qin, et al.
NPJ Parkinson'S Disease|October 11, 2024
Machine learning model base on metabolomics and proteomics to predict cognitive impairment in Parkinson's diseaseBaiyuan Yang, Yongyun Zhu, Kelu Li, et al.
Angewandte Chemie (International Ed. in English)|February 2, 2018
Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial ActivityMichael B Harbut, Baiyuan Yang, Renhe Liu, et al.
The Journal of Biological Chemistry|December 10, 2025
Inhibition of de novo fatty acid synthesis in Mycobacterium tuberculosisEmma K Roszkowski, Sarita Charap, Christine R Montague, et al.
Angewandte Chemie (International Ed. in English)|August 18, 2017
Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular ThiophenesRenhe Liu, Xiaoxuan Lyu, Sarah M Batt, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2018
Repurposing isoxazoline veterinary drugs for control of vector-borne human diseasesMarie Miglianico, Maarten Eldering, Hannah Slater, et al.
Nature|July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.
Science Translational Medicine|May 10, 2019
Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infectionsMalina A Bakowski, Roohollah Kazem Shiroodi, Renhe Liu, et al.
Pageof 5